The Valley Desk

ArticleExploration of targeted anti-tumor therapyPublished

Receptor tyrosine kinase-like orphan receptor 1 inhibitor strictinin exhibits anti-cancer properties against highly aggressive androgen-independent prostate cancer

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Philadelphia College of Osteopathic Medicine, Saint Joseph’s University. Affiliation source

Publication record

Type
Article
Venue
Exploration of targeted anti-tumor therapy
Published
Subject terms
Receptor tyrosine kinase; Oncology; prostate cancer; Castration-resistant Prostate Cancer; Small Molecule Inhibitors; Strictinin; Natural Therapy; Receptor Tyrosine Kinase-like Orphan Receptor 1
PubMed ID
38213538
PubMed Central ID
PMC10784114
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal